Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-02-12
1995-03-21
Henley, III, Raymond
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 31425
Patent
active
053995716
ABSTRACT:
A neuroprotecting drug comprises as an essential active ingredient ethyl 2-[4,5-bis(4-methoxyphenyl)thiazol-2-yl]pyrrol-1-yl acetate, which is useful with high safety for the prophylaxis and treatment of brain dysfunction induced by hypoxia due to the disturbance of cerebral circulation such as cerebral hemorrhage or cerebral infarction in human being.
REFERENCES:
patent: 4168315 (1979-09-01), Rynbrandt et al.
patent: 4659726 (1987-04-01), Yoshino et al.
Seminars in Neurology, vol. 11, No. 4, Dec. 1991, pp. 353-367, J. Biller et al. `Antithrombotic therapy for ischemic cerebrovascular disease`.
Dialog Information Services, File 55, Accession No. 9325804 & JPN J Pharmacol (Suppl. 1), vol. 59, 1992, p. 346P, N. Yamamoto et al., `Protective effect of KBT-3022 a new anti-platelet agent in experimental cerebral ischemic models`.
Ito Keizo
Yamamoto Noriko
Yamashita Akira
Yokota Koichi
Henley III Raymond
Kanebo Ltd.
Weddington K.
LandOfFree
Neuroprotective drug does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Neuroprotective drug, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Neuroprotective drug will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1149127